Although several drugs can control the burden of PAH symptoms, including phosphodiesterase type 5 inhibitors, soluble guanylate cyclase stimulators, prostacyclin analogs, prostacyclin receptor agonists, and endothelin receptors antagonists, they still cannot cure or reverse the progression of PAH [5]. Here, PTGIR is linked to pulmonary arterial hypertension.